Skip to main content
. 2014 Sep 22;2014:719478. doi: 10.1155/2014/719478

Table 2.

Oral procedures in patients with current/past or planned BP therapy [28].

Malignancies Osteometabolic disorders
Treatment Planned BF therapy Current/past BF therapy Planned or <3 years of NBP therapy >3 years of NBP therapy or <3 years with risk factors for BRONJ
Dentoalveolar surgery Extractive procedures Recommended Recommended Recommended Recommended
Simple extraction1 Surgical extraction2 Simple extraction Surgical extraction2
To wait until mucosal healing before starting BF therapy (4–6 weeks) Recommended therapy suspension  from extraction day until mucosal healing (4–6 weeks)
Preimplant surgery Not recommended Not recommended Possible Possible4

Implantology Not recommended Not recommended Possible3 Possible3,4

Periodontal surgery Therapeutic Recommended2,5 Recommended2,5 Recommended Recommended2
To wait until mucosal healing before starting BF therapy Recommended therapy suspension
(4–6 weeks) from extraction day until mucosal healing
(4–6 weeks)
Elective Not recommended Not recommended Possible Possible

Endodontic surgery Recommended2,5 Recommended2,5 Recommended Recommended2

Periodontal therapy (scaling/root planning) Recommended Recommended Recommended Recommended
(every 4 months) (every 4–6 months)

Conservative Recommended Recommended Recommended Recommended

Endodontics Recommended Recommended Recommended Recommended

Orthodontics Possible Possible (recommended low orthodontic forces) Possible Possible

Fixed prosthesis Possible Possible6 Possible Possible6

Removable prosthesis Possible Possible Possible Possible
Avoid injuries and pressure sores, to use soft liners eventually Avoid injuries and pressure sores, to use soft liners eventually
(control of the prosthesis every 4 months) (control of the prosthesis every 4–6 months)

1If BP therapy cannot be delayed, choose surgical extraction; 2use mucoperiosteal flap for primary closure of the surgical site; 3informed consent for not defined long-term BRONJ risk; 4informed consent for not defined short-term BRONJ risk; 5only for the treatment of significant infectious-inflammatory processes, not otherwise controllable using noninvasive methods; 6respect of the biological width (control of cervical closure-possible supragingival closure).